TH9619

One-carbon Therapeutics AB · Phase 1 active Small molecule

At a glance

Generic name	TH9619
Sponsor	One-carbon Therapeutics AB
Modality	Small molecule
Phase	Phase 1

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

Phase 1/2 Study to Evaluate TH9619 in the Treatment of Advanced Solid Tumors (PHASE1, PHASE2)

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

Source	Used for
ClinicalTrials.gov	Trial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

TH9619 CI brief — competitive landscape report
TH9619 updates RSS · CI watch RSS
One-carbon Therapeutics AB portfolio CI